Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.arcmed.2020.03.011 http://scihub22266oqcxt.onion/10.1016/j.arcmed.2020.03.011 32279908!7128661!32279908     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32279908&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Med+Res 2020 ; 51 (4): 345-346 Nephropedia Template TP {{tp|p=32279908|t=2020. Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?|pdf=|usr=}}{{32279908}} gab.com Text Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection JO: Arch Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32279908 #FOAvip In the recent coronavirus disease (COVID-19) outbreak, a higher proportion of patients with severe disease were found in older persons with comorbidities. This observation has been related to the use of drugs that can increase the cellular expression of angiotensin-converting enzyme 2 (ACE2) that has been recognized as target to which the virus bind to cells. Although this hypothesis is possible, it may also have other explanations which are discussed. Twit Text FOAVip Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection ????Arch Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32279908 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32279908 #FOAvip English Wikipedia <ref>{{Cite pmid|32279908}}</ref> Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? #MMPMID32279908 Gracia-Ramos AE Arch Med Res 2020[May]; 51 (4): 345-346 PMID32279908show ga In the recent coronavirus disease (COVID-19) outbreak, a higher proportion of patients with severe disease were found in older persons with comorbidities. This observation has been related to the use of drugs that can increase the cellular expression of angiotensin-converting enzyme 2 (ACE2) that has been recognized as target to which the virus bind to cells. Although this hypothesis is possible, it may also have other explanations which are discussed. |Angiotensin-Converting Enzyme 2[MESH] |Animals[MESH] |Betacoronavirus/*pathogenicity[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Coronavirus Infections/*enzymology/pathology/virology[MESH] |Humans[MESH] |Male[MESH] |Mice[MESH] |Pandemics[MESH] |Peptidyl-Dipeptidase A/metabolism[MESH] |Pneumonia, Viral/*enzymology/pathology/virology[MESH] |Rats[MESH] |Rats, Sprague-Dawley[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?(epmc).pdf DeepDyve Pubget Overpricing